Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey R Strawn

Showing results (21-30 of 233) with videos related to

Pageof 24
Sort By:
Paediatric Drugs|December 15, 2015
Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and TolerabilityEric T Dobson, Jeffrey R Strawn
The Annals of Pharmacotherapy|November 26, 2011
Successful treatment of posttraumatic stress disorder with prazosin in a young childJeffrey R Strawn, Brooks R Keeshin
Journal of Child Psychology and Psychiatry, and Allied Disciplines|February 9, 2020
Commentary: Treatment failure and success: a commentary on defining and treating pediatric treatment-resistant depression - reflections on Dwyer et al. (2020)Jeffrey R Strawn, Paul E Croarkin
Journal of the American Academy of Child and Adolescent Psychiatry|November 5, 2019
Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-analysisJeffrey A Mills, Jeffrey R Strawn
Journal of Child and Adolescent Psychopharmacology|January 17, 2024
Response to Plöderl et al. re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder"Jeffrey R Strawn, Jeffrey A Mills
The Lancet. Psychiatry|June 22, 2020
Identifying the best treatment for young people with depressionJeffrey R Strawn, John T Walkup
Journal of Child and Adolescent Psychopharmacology|February 20, 2024
The Pharmacogenetic Journey in Child and Adolescent Psychopharmacology: Are We There Yet?Lisa B Namerow, Jeffrey R Strawn
Journal of Child and Adolescent Psychopharmacology|April 6, 2018
Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology ResearchJeffrey R Strawn, Paul E Croarkin
Bulletin of the Menninger Clinic|March 14, 2012
Termination of psychodynamic psychotherapy with adolescents: A review and contemporary perspectiveSergio V Delgado, Jeffrey R Strawn
Expert Opinion on Pharmacotherapy|January 29, 2008
Olanzapine for the treatment of bipolar disorder in children and adolescentsJeffrey R Strawn, Melissa P Delbello
Pageof 24

Showing results (21-30 of 233) with videos related to

Sort By:
Pageof 24
Paediatric Drugs|December 15, 2015
Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and TolerabilityEric T Dobson, Jeffrey R Strawn
The Annals of Pharmacotherapy|November 26, 2011
Successful treatment of posttraumatic stress disorder with prazosin in a young childJeffrey R Strawn, Brooks R Keeshin
Journal of Child Psychology and Psychiatry, and Allied Disciplines|February 9, 2020
Commentary: Treatment failure and success: a commentary on defining and treating pediatric treatment-resistant depression - reflections on Dwyer et al. (2020)Jeffrey R Strawn, Paul E Croarkin
Journal of the American Academy of Child and Adolescent Psychiatry|November 5, 2019
Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-analysisJeffrey A Mills, Jeffrey R Strawn
Journal of Child and Adolescent Psychopharmacology|January 17, 2024
Response to Plöderl et al. re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder"Jeffrey R Strawn, Jeffrey A Mills
The Lancet. Psychiatry|June 22, 2020
Identifying the best treatment for young people with depressionJeffrey R Strawn, John T Walkup
Journal of Child and Adolescent Psychopharmacology|February 20, 2024
The Pharmacogenetic Journey in Child and Adolescent Psychopharmacology: Are We There Yet?Lisa B Namerow, Jeffrey R Strawn
Journal of Child and Adolescent Psychopharmacology|April 6, 2018
Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology ResearchJeffrey R Strawn, Paul E Croarkin
Bulletin of the Menninger Clinic|March 14, 2012
Termination of psychodynamic psychotherapy with adolescents: A review and contemporary perspectiveSergio V Delgado, Jeffrey R Strawn
Expert Opinion on Pharmacotherapy|January 29, 2008
Olanzapine for the treatment of bipolar disorder in children and adolescentsJeffrey R Strawn, Melissa P Delbello
Pageof 24